Literature DB >> 7588176

[Spontaneous course of depression].

J M Azorin1.   

Abstract

The study of the spontaneous course of depressions nowadays comes up against a number of obstacles. The most important of these is the necessity of using untreated cases, which virtually forces the contemporary researcher to refer to studies performed in the pretherapeutic era, if conclusions are not be drawn only from classical descriptions. Unfortunately, these studies are marked by the absence of strict diagnostic criteria, the heterogeneity of patients included in them, the lack of preciseness of evaluations and the primitive statistical methods used. They are concerned essentially with the duration of depressive phases and the factors which influence it. Among these latter are regularly found age, sex, the number of episodes, the duration of the preceding symptom-free interval, the severity and semiology of the attack, heredity, mode of onset, level of intelligence, the presence or absence of associated pathology and the presence or absence of hospitalisation. Chronicization of depression and the factors concerned with it have also been the object of several studies. A small number of investigations compare the course of the illness in untreated populations. The study of the spontaneous course of depression evidences the necessity of having consensus definitions, and may serve as a basis for a better comprehension of the process of cure and of the real impact of therapies designed to treat depression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588176

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  1 in total

1.  New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression: application to a one-year double-blind study comparing medifoxamine with fluoxetine.

Authors:  P Lehert; M F Poirier-Littre; D Pringuey; A Galinowski
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.